Profilo
Mr. Michal Fisher is an Independent Director at CNS Pharmaceuticals, Inc. and a Chief Business Officer at BioGenCell Ltd. He is on the Board of Directors at CNS Pharmaceuticals, Inc. Mr. Fisher was previously employed as a Head-Corporate Development by LifeSci Partners.
He received his undergraduate degree from Bar-Ilan University and a graduate degree from Bar-Ilan University.
Posizioni attive di Michal Fisher
| Società | Posizione | Inizio |
|---|---|---|
| CNS PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 04/05/2026 |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Corporate Officer/Principal | - |
Precedenti posizioni note di Michal Fisher
| Società | Posizione | Fine |
|---|---|---|
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Corporate Officer/Principal | 02/01/2025 |
Formazione di Michal Fisher
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Bar-Ilan University
Bar-Ilan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioGenCell Ltd.
BioGenCell Ltd. BiotechnologyHealth Technology Develops cellular therapies that treat blood flow problems | Health Technology |
CNS Pharmaceuticals, Inc.
CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
LifeSci Partners
LifeSci Partners Miscellaneous Commercial ServicesCommercial Services Operates as an integrated life sciences consulting platform that offers investor relations, investment banking, communications and strategy consulting | Commercial Services |
















